Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases: Findings From the NRG-BR001 Phase 1 Trial

IMPORTANCE: Stereotactic body radiotherapy (SBRT) for oligometastases is hypothesized to improve survival and is increasingly used. Little evidence supports its safe use to treat patients with multiple metastases. OBJECTIVE: To establish safety of SBRT dose schedules in patients with 3 to 4 metastas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Chmura, Steve, Winter, Kathryn A., Robinson, Clifford, Pisansky, Thomas M., Borges, Virginia, Al-Hallaq, Hania, Matuszak, Martha, Park, Sean S., Yi, Sun, Hasan, Yasmin, Bazan, Jose, Wong, Philip, Yoon, Harold A., Horton, Janet, Gan, Gregory, Milano, Michael T., Sigurdson, Elin Ruth, Moughan, Jennifer, Salama, Joseph K., White, Julia
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2021
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8063134/
https://ncbi.nlm.nih.gov/pubmed/33885704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2021.0687
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados